when was glp-1 discovered Timeline of discovery and drug development Glucagon-like peptide-1 receptor: mechanisms and

As a triple agonist, retatrutide stimulates three potent hormone receptors that control energy balance, metabolism, and weight: Glucagon-Like Peptide-1, or GLP-1: Diminishes appetite Delays the emptying of the stomach Enhances blood sugar regulation Glucose-Dependent Insulinotropic Polypeptide, or GIP: Improves the response to insulin Promotes metabolic adaptability Enhances the use of nutrients The glucagon receptor: Raises energy costs Encourages the burning of fat Aids in the mobilization of fat reserves Compared to single-agonist or dual-agonist therapies, the synergistic effect of these triple agonists results in more effective and long-lasting weight loss

Calculate and code RISK score : This can be calculated via the Diabetes UK Know Your Risk Tool , which requires patients to measure height, weight and waist circumference, or the Leicester diabetes score (abbreviated form the DUK know your risk tool) which is available on Vision+ NICE guidelines encourage keeping an up to date register of RISK scores, along with introducing a recall system to invite those at risk of Type 2 Diabetes in for regular review

Suboptimal Breastfeeding in the United States: Maternal and Pediatric Health Outcomes and Costs

Slowing gastric emptying: Food stays in the stomach longer and is better absorbed as it moves more slowly through the intestines

Peppermint tea or peppermint oil capsules may also help relax the gut and reduce bloating

& Sturmer, T